The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation.
Members of the organic cation transporter (OCT) family are mainly expressed in kidney, liver, intestine, and brain. The regulation of the OCT type 1 from rat (rOCT1) stably transfected in HEK293 cells was examined using a fluorimetric technique, 1-[(3)H]methyl-4-phenylpyridinium uptake studies, and fast-whole-cell patch-clamp recordings. For the fluorescence measurements, the cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP(+)) was used as substrate. Uptake of ASP(+) via rOCT1 was electrogenic, and its inhibition by other organic cations was consistent with previously reported radioactive tracer flux measurements. The inhibitor quinine was not translocated by the organic cation transporter in contrast to tetraethylammonium. Stimulation of diacyl glycerol-dependent protein kinase C (PKC) by sn-1,2-dioctanoyl glycerol (1 microM) resulted in an increase in initial ASP(+) uptake rate by 216 +/- 28% (n = 29). The effect was completely antagonized by the PKC inhibitor tamoxifen (20 microM, n = 22). Forskolin (1 microM), which activates adenylate cyclase and thereby protein kinase A (PKA), stimulated the initial rate of ASP(+) accumulation by 51 +/- 6% (n = 19). This effect was inhibited by the specific PKA inhibitor KT5720 (1 microM, n = 12). Inhibition of tyrosine kinases by aminogenestein (10 microM) reduced ASP(+) uptake by 63 +/- 7% (n = 7), while genestein or tyrphostin AG1295 (each 10 microM) were without significant effects. Incubation of the cells with sn-1, 2-dioctanoyl glycerol (1 microM) increased the affinities of the transporter to tetraethylammonium, tetrapenthylammonium, and quinine by a factor of 58, 14.5, and 2.4, respectively. Western blot analysis revealed that rOCT1 protein was phosphorylated at a serine residue upon stimulation of PKC. In conclusion, it has been demonstrated that the organic cation transport by rOCT1 is stimulated by PKC, PKA, and endogenous tyrosine kinase activation. The PKC phosphorylates rOCT1 and leads to a conformational change at the substrate binding site.
Mehrens
Thomas
T
Medizinische Poliklinik, Experimentelle Nephrologie, Westfälische Wilhelms-Universität Münster, Germany.
Lelleck
Silke
S
Medizinische Poliklinik, Experimentelle Nephrologie, Westfälische Wilhelms-Universität Münster, Germany.
Çetinkaya
Ibrahim
I
Medizinische Poliklinik, Experimentelle Nephrologie, Westfälische Wilhelms-Universität Münster, Germany.
Knollmann
Marion
M
Medizinische Poliklinik, Experimentelle Nephrologie, Westfälische Wilhelms-Universität Münster, Germany.
Hohage
Helge
H
Medizinische Poliklinik, Experimentelle Nephrologie, Westfälische Wilhelms-Universität Münster, Germany.
Gorboulev
Valentin
V
Anatomisches Institut, Universität Würzburg, Germany.
Bokník
Peter
P
Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität Münster, Germany.
Koepsell
Hermann
H
Anatomisches Institut, Universität Würzburg, Germany.
Schlatter
Eberhard
E
Medizinische Poliklinik, Experimentelle Nephrologie, Westfälische Wilhelms-Universität Münster, Germany.
D000818:Animals; D001667:Binding, Competitive; D001692:Biological Transport / Q000502:physiology; D002352:Carrier Proteins / Q000378:metabolism*; D002460:Cell Line; D004594:Electrophysiology; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism*; D008856:Microscopy, Fluorescence; D027702:Organic Cation Transporter 1; D010766:Phosphorylation; D011493:Protein Kinase C / Q000378:metabolism / Q000502:physiology*; D011494:Protein Kinases / Q000502:physiology; D011726:Pyridinium Compounds / Q000493:pharmacokinetics; D051381:Rats
D002352:Carrier Proteins; D008565:Membrane Proteins; D027702:Organic Cation Transporter 1; D011726:Pyridinium Compounds; C011786:2-(4-(dimethylamino)styryl)-1-methylpyridinium; D011494:Protein Kinases; D011493:Protein Kinase C